Cohen Capital Management’s Boston Scientific BSX Stock Holding History

Cohen Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,416	Closed	-$277K	–	154
2026 Q1	$277K	Buy	4,416 +16	+0.4%	+$1.28K	0.04%	139
2025 Q4	$420K	Hold	4,400	–	–	0.06%	123
2025 Q3	$430K	Hold	4,400	–	–	0.07%	119
2025 Q2	$473K	Hold	4,400	–	–	0.08%	117
2025 Q1	$444K	Hold	4,400	–	–	0.08%	118
2024 Q4	$393K	Hold	4,400	–	–	0.07%	123
2024 Q3	$369K	Hold	4,400	–	–	0.06%	126
2024 Q2	$339K	Hold	4,400	–	–	0.06%	123
2024 Q1	$301K	Hold	4,400	–	–	0.05%	124
2023 Q4	$254K	Hold	4,400	–	–	0.05%	125
2023 Q3	$232K	Hold	4,400	–	–	0.05%	126
2023 Q2	$238K	Hold	4,400	–	–	0.05%	128
2023 Q1	$220K	Hold	4,400	–	–	0.04%	132
2022 Q4	$204K	Buy	+4,400	New	+$191K	0.04%	136
2020 Q1	–	Sell	-2,375	Closed	-$107K	–	130
2019 Q4	$107K	Buy	+2,375	New	+$99.4K	0.02%	133

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Cohen Capital Management's BSX Position: Q2 2026 in Review

Cohen Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,416 shares — an estimated $277K sold.

Cohen Capital Management first reported a position in BSX in Q4 2019 and held it in 15 quarters. The position peaked at $473K in Q2 2025. 550 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cohen Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Cohen Capital Management sold 4,416 Boston Scientific shares in Q2 2026, an estimated $277K.
Cohen Capital Management first reported a position in Boston Scientific in Q4 2019 and held it in 15 quarters.
Cohen Capital Management's Boston Scientific position peaked at $473K in Q2 2025.
550 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.